Uni of Dundee, Eisai join forces for cancer drug discovery
The collaboration research agreement regards Proteolysis Targeting Chimeras, or PROTACs.
Read More
Tag: PROTACs
Pfizer, Arvinas to collaborate on PROTACs
Arvinas and Pfizer have signed a research collaboration and license agreement relating to the discovery and development of protein degradation drug candidates
Read More
- UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
- Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
